Meeting of the National Vaccine Advisory Committee, 2075-2076 [E9-498]

Download as PDF Federal Register / Vol. 74, No. 9 / Wednesday, January 14, 2009 / Notices Officers: Valentine D. Heger, V. Pres. International, (Qualifying Individual), Nick Byers, President. America Global Logistics, LLC, 1335 NW 98th Court, Doral, FL 33172, Officers: Christian M. Ollino, Managing Member, (Qualifying Individual), Alejo J. Aguilar, Director. Rax International, Inc., 2600 71st Street, North Bergen, NJ 07047, Officer: Sungkyu Chae, President, (Qualifying Individual). Global Forwarding Enterprises Limited Liability Co., 49 Hedgerow Lane, Manalapan, NJ 07726, Officers: Marty A. Kavanagh, Manager, (Qualifying Individual), Pavel Kapelnikov, Gen. Manager. Encompas Global Logistics LLC, 17890 Castleton Street, Ste. 368, City of Industry, CA 91748, Officer: Asa Cheng, President, (Qualifying Individual). also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than January 30, 2009. A. Federal Reserve Bank of Atlanta (Steve Foley, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: 1. Marshall Truman Reynolds and Douglas Vernon Reynolds, both of Huntington, West Virginia, Samuel George Kapourales, Williamson, West Virginia, and Todd R. Fry, Barboursville, West Virginia; to retain 6.64 percent of the outstanding shares of American Gateway Financial Corporation, Port Allen, Louisiana, and its subsidiary, American Gateway Bank, Baton Rouge, Louisiana. Ocean Freight Forwarder—Ocean Transportation Intermediary Applicants Board of Governors of the Federal Reserve System, January 9, 2009. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E9–589 Filed 1–13–09; 8:45 am] Integrated Alliance Corp., 61–36 233rd Street, Bayside, NY 11364, Officers: George Matthes, Secretary, (Qualifying Individual), Adam Chi, President. Fettig & Donalty, Inc., 1225 Eye St., NW., Ste. 1200, Washington, DC 20006, Officers: Michael S. Lagoon, Director, (Qualifying Individual), Shaikh Hamid, Vice President. Deaking Trans-Global Logistics, LLC, 6817 South Point Parkway, Jacksonville, FL 32216, Officers: Iris M. Starling, Vice President, (Qualifying Individual), John P. Deakins, President. Dated: January 9, 2009. Karen V. Gregory, Secretary. [FR Doc. E9–700 Filed 1–13–09; 8:45 am] BILLING CODE 6730–01–P FEDERAL RESERVE SYSTEM sroberts on PROD1PC70 with NOTICES Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices VerDate Nov<24>2008 22:13 Jan 13, 2009 Jkt 217001 BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 2075 holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than February 9, 2009. A. Federal Reserve Bank of Chicago (Burl Thornton, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414: 1. Tygris Commercial Financial Group, Inc., Parsippany, New Jersey; to become a bank holding company by acquiring 100 percent of the voting shares of Texico Bancshares Corporation, Texico, Illinois, and thereby indirectly acquire Texico State Bank, Texico, Illinois. In connection with this proposal, applicant also has applied to engage in lending and leasing activities through Tygris Vendor Finance, Inc., Parsippany, New Jersey; Tygris Asset Finance, Inc., Chicago, Illinois; Tygris Corporate Finance, Inc., Wilton, Connecticut; TAF Funding I, LLC, Chicago, Illinois; USXL Funding I, LLC, Parsippany, New Jersey; USXL Funding II, LLC, Parsippany, New Jersey; and Pro-Lease, Inc., Parsipany, New Jersey, pursuant to section 225.28 (b)(1), (2) and (3) of Regulation Y. Board of Governors of the Federal Reserve System, January 9, 2009. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E9–590 Filed 1–13–09; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice of meeting. SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail nvpo@hhs.gov or call 202–690–5566. E:\FR\FM\14JAN1.SGM 14JAN1 sroberts on PROD1PC70 with NOTICES 2076 Federal Register / Vol. 74, No. 9 / Wednesday, January 14, 2009 / Notices Audio conferencing will be available for the second day of the meeting. DATES: The meeting will be held on February 5, 2009, from 8:30 a.m. to 6:30 p.m. and on February 6, 2009, from 8 a.m. to 3:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, National Vaccine Program Office, Department of Health and Human Services, Room 443-H, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260–1165; e-mail: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Topics to be discussed at the meeting on Thursday, February 5, 2009 include vaccine financing, vaccine safety, vaccine stockpile, seasonal influenza and related issues, vaccine development, and the National Vaccine Plan. Updates will be given by the NVAC Financing, Adult Immunization, and Safety working groups. The meeting on Friday, February 6, 2009 is a full day stakeholders’ meeting to discuss the draft strategic National Vaccine Plan. The draft plan can be viewed at the following Web site: https://www.hhs.gov/ nvpo/vacc_plan/. The meeting will begin with a plenary session to provide an overview of the day’s agenda followed by break-out sessions for each of the five draft strategic National Vaccine Plan goals. Audio-conferencing will be available for the stakeholders’ meeting on February 6, 2009 for the plenary as well as break-out sessions. Call-in numbers for the meeting are as follows: plenary sessions on February 6: (888) 390–3413 (passcode: 60302); goal 1: research (888) 469–1340 (passcode 27271); goal 2: safety (888) 989–4406 (passcode 41520); goal 3: communication (800) 779–6844 (passcode 19562); goal 4: supply (888) VerDate Nov<24>2008 21:01 Jan 13, 2009 Jkt 217001 994–8791 (passcode 37886); and goal 5: global health (888) 989–4717 (passcode 12377). Agendas for each day of the meeting will be posted on the NVAC Web site: www.hhs.gov/nvpo/nvac by January 21, 2009. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Individuals who would like to submit written statements should e-mail or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. A separate Federal Register Notice will be issued with detailed instructions for submitting comments about the draft strategic National Vaccine Plan. Any members of the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business January 30, 2009. Dated: January 5, 2009. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. E9–498 Filed 1–13–09; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute for Occupational Safety and Health; Decision To Evaluate a Petition To Designate a Class of Employees for the Piqua Organic Moderated Reactor Site, Piqua, Ohio, To Be Included in the Special Exposure Cohort AGENCY: National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. SUMMARY: HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees for the Piqua Organic Moderated Reactor site, Piqua, Ohio, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 warranted by the evaluation, is as follows: Facility: Piqua Organic Moderated Reactor site. Location: Piqua, Ohio. Job Titles and/or Job Duties: All employees associated with reactor activities who worked within and around the Reactor Dome. Period of Employment: January 1, 1963 through December 31, 1966. FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. Dated: January 6, 2009. Christine M. Branche, Acting Director, National Institute for Occupational Safety and Health. [FR Doc. E9–571 Filed 1–13–09; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of Written Comments on Draft Strategic National Vaccine Plan AGENCY: Department of Health and Human Services, Office of the Secretary. ACTION: Notice. SUMMARY: On behalf of the National Vaccine Advisory Committee (NVAC), the National Vaccine Program Office (NVPO) is soliciting public comment on the draft strategic National Vaccine Plan. DATES: All comments on the draft strategic National Vaccine Plan should be received no later than 5 p.m. on January 30, 2009. ADDRESSES: Electronic responses are preferred and may be addressed to NVPComments@hhs.gov. Written responses should be addressed to National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Washington, DC 20201, Attention: National Vaccine Plan RFI. FOR FURTHER INFORMATION CONTACT: CAPT Raymond A. Strikas, M.D., National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Washington, DC 20201; (202) 690–5566; fax 202–260– 1165; e-mail nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: E:\FR\FM\14JAN1.SGM 14JAN1

Agencies

[Federal Register Volume 74, Number 9 (Wednesday, January 14, 2009)]
[Notices]
[Pages 2075-2076]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-498]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Any individual who 
wishes to attend the meeting and/or participate in the public comment 
session should e-mail nvpo@hhs.gov or call 202-690-5566.

[[Page 2076]]

Audio conferencing will be available for the second day of the meeting.

DATES: The meeting will be held on February 5, 2009, from 8:30 a.m. to 
6:30 p.m. and on February 6, 2009, from 8 a.m. to 3:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, National Vaccine 
Program Office, Department of Health and Human Services, Room 443-H, 
Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, 
DC 20201. Phone: (202) 690-5566; Fax: (202) 260-1165; e-mail: 
nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health 
and Human Services was mandated to establish the National Vaccine 
Program to achieve optimal prevention of human infectious diseases 
through immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program, on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Topics to be discussed at the meeting on Thursday, February 5, 2009 
include vaccine financing, vaccine safety, vaccine stockpile, seasonal 
influenza and related issues, vaccine development, and the National 
Vaccine Plan. Updates will be given by the NVAC Financing, Adult 
Immunization, and Safety working groups. The meeting on Friday, 
February 6, 2009 is a full day stakeholders' meeting to discuss the 
draft strategic National Vaccine Plan. The draft plan can be viewed at 
the following Web site: https://www.hhs.gov/nvpo/vacc_plan/. The 
meeting will begin with a plenary session to provide an overview of the 
day's agenda followed by break-out sessions for each of the five draft 
strategic National Vaccine Plan goals. Audio-conferencing will be 
available for the stakeholders' meeting on February 6, 2009 for the 
plenary as well as break-out sessions. Call-in numbers for the meeting 
are as follows: plenary sessions on February 6: (888) 390-3413 
(passcode: 60302); goal 1: research (888) 469-1340 (passcode 27271); 
goal 2: safety (888) 989-4406 (passcode 41520); goal 3: communication 
(800) 779-6844 (passcode 19562); goal 4: supply (888) 994-8791 
(passcode 37886); and goal 5: global health (888) 989-4717 (passcode 
12377). Agendas for each day of the meeting will be posted on the NVAC 
Web site: www.hhs.gov/nvpo/nvac by January 21, 2009.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person at least one week prior to the 
meeting. Members of the public will have the opportunity to provide 
comments at the meeting. Public comment will be limited to five minutes 
per speaker. Individuals who would like to submit written statements 
should e-mail or fax their comments to the National Vaccine Program 
Office at least five business days prior to the meeting. A separate 
Federal Register Notice will be issued with detailed instructions for 
submitting comments about the draft strategic National Vaccine Plan. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, through the contact person listed above prior to close of 
business January 30, 2009.

    Dated: January 5, 2009.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine 
Program Office.
[FR Doc. E9-498 Filed 1-13-09; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.